🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Material Elimination

Based on TikTok, the platform has removed violative content and prohibited related hashtags and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of weight loss, positive testimonials and step-by-step guides for preparing or injecting at residence.

Within minutes of joining one group, a seller shared WhatsApp details, where most transactions take place. The seller sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Item Information and Pricing

Within these groups, posts show black plastic parcels with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they can’t verify. Even if the research behind this drug is valid, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to potentially significant health risks”.